OXBRW Oxbridge Re Holdings Limited - Warrant
NASDAQ · SEC EDGAR'da Görüntüle ↗ kapat Eki 1, 2026 10-K/10-Q Ağu 13, 2026
$0,12
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$0,0752 haftanın en düşüğü
$0,2652 haftanın en yükseği
Piyasa Değeri (MRQ)
$980.3K
P/E
-0.9
Hisse Başına Kâr
$-0.28
Gelir
$3M
rozetleriniz
52 Haftlık Aralık
$0–$0
Analist Derecelendirmesi
·
Fiyat Hedefi
·
P/E
-0.9
ROE
·
Net Kâr Marjı
4.7%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
OXBRW Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$0.12
Piyasa Değeri (MRQ)
$980.3K
P/E
-0.9
Hisse Başına Kâr
$-0.28
Gelir
$3M
D/E Borç/Özsermaye (MRQ)
0.0
52 Haftlık Aralık
$0–$0
OXBRW Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$3M2016-12-31 → 2025-12-31
Hisse Başına Kâr$-0.282016-12-31 → 2025-12-31
Serbest Nakit Akışı·2016-12-31 → 2023-12-31
Net kar marjı4.7%2016-12-31 → 2024-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | OXBRW | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -0.9 | · | · | · | |
| F/S (TTM) | 0.4 | · | · | · | |
| F/D (MRQ) | 0.1 | · | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 0.3 | · | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | OXBRW | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Vergi Öncesi Kar Marjı (TTM) | 13.7%5Y ort. ≈-123.4% | ≈-123.4% | · | · | |
| Net Kâr Marjı (TTM) | 4.7%5Y ort. ≈-189.7% | ≈-189.7% | · | · |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | OXBRW | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Borç / Öz Sermaye (MRQ) | 0.0 | · | · | · |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | OXBRW | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 372.0%5Y ort. ≈340.9% | ≈340.9% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 44.7% | · | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 16.2% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | OXBRW | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue / Employee (Çalışan Başına Gelir) | ≈$644.2K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3M | $546.0K | $-7M | $850.0K | $10M | $1M | $981.0K | $4M | $24M | $19M | $6M | $6M | |
| SG&A Expense | $3M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Operating Expenses | $6M | $2M | · | $3M | $2M | $1M | $1M | $12M | $44M | $16M | $2M | $2M | |
| Pretax Income | $-2M | $-3M | $-9M | $-2M | $9M | $88.0K | $-150.0K | $-8M | $-21M | · | · | · | |
| Net Income | $-2M | $-3M | $-10M | $-2M | $9M | $-50.0K | $-305.0K | $-6M | $-21M | $3M | $5M | $4M | |
| EPS (Basic) | $-0.28 | $-0.45 | $-1.69 | $-0.31 | $1.49 | $-0.01 | $-0.05 | $-1.00 | $-3.55 | $0.43 | $0.76 | $0.82 | |
| EPS (Diluted) | $-0.28 | $-0.45 | $-1.69 | $-0.31 | $1.49 | $-0.01 | $-0.05 | $-1.00 | $-3.55 | $0.43 | $0.76 | $0.82 | |
| Shares (Basic) | 7,389,822 | 6,099,051 | 5,867,129 | 5,772,396 | 5,735,779 | 5,733,587 | 5,733,587 | 5,733,587 | 5,808,354 | 6,022,985 | 6,056,219 | 4,862,479 | |
| Shares (Diluted) | 7,389,822 | 6,099,051 | 5,867,129 | 5,772,396 | 5,735,779 | 5,733,587 | 5,733,587 | 5,733,587 | 5,808,354 | 6,022,985 | 6,056,219 | 4,862,479 |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $268.0K | $2M | $495.0K | $1M | $4M | $7M | $8M | $8M | $8M | $36M | $9M | $5M | |
| Receivables | · | · | $100.0K | · | · | · | · | · | · | · | · | · | |
| PP&E (Net) | $16.0K | $1.0K | $4.0K | $5.0K | $9.0K | $13.0K | $9.0K | $18.0K | $36.0K | $54.0K | $64.0K | $46.0K | |
| PP&E (Gross) | $146.0K | $135.0K | $135.0K | $130.0K | $130.0K | $127.0K | $113.0K | $112.0K | $112.0K | $106.0K | $95.0K | $59.0K | |
| Accum. Depreciation | $130.0K | $134.0K | $131.0K | $125.0K | $121.0K | $114.0K | $104.0K | $94.0K | $76.0K | $52.0K | $31.0K | $13.0K | |
| Total Assets | $8M | $7M | $8M | $17M | $18M | $9M | $9M | $13M | $21M | $51M | $53M | $50M | |
| Short-term Debt | $118.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $2M | $2M | $3M | $2M | $1M | $1M | $1M | $4M | $7M | $14M | $16M | $13M | |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | |
| Paid-in Capital | $38M | $34M | · | · | $32M | $32M | · | · | · | · | · | $34M | |
| Retained Earnings | $-32M | $-30M | $-27M | $-17M | $-16M | $-24M | $-24M | $-24M | $-18M | $5M | $5M | $3M | |
| AOCI | · | · | · | · | · | · | $0 | $2.0K | $-39.0K | $-411.0K | $-1M | $17.0K | |
| Stockholders' Equity | $6M | $4M | $5M | $15M | $17M | $8M | $8M | $8M | $14M | $37M | $37M | $37M | |
| Liabilities + Equity | $8M | $7M | $8M | $17M | $18M | $9M | $9M | $13M | $21M | $51M | $53M | $50M | |
| Shares Outstanding | 7,664,122 | 6,379,002 | 5,870,234 | 5,769,587 | 5,749,587 | 5,733,587 | 5,733,587 | 5,733,587 | 5,916,149 | 5,916,149 | 6,060,000 | 6,000,000 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.0K | $3.0K | $6.0K | $4.0K | $7.0K | · | · | · | · | · | · | · | |
| Stock-based Comp | $418.0K | $234.0K | $258.0K | $127.0K | $61.0K | $32.0K | $36.0K | $126.0K | $127.0K | $119.0K | $117.0K | $0 | |
| Operating Cash Flow | $-1M | $-284.0K | $-1M | $-829.0K | $-253.0K | $-266.0K | $-4M | $-7M | $-26M | $416.0K | $8M | $9M | |
| CapEx | $16.0K | · | $5.0K | · | $3.0K | $14.0K | $1.0K | $0 | $6.0K | $11.0K | $36.0K | $59.0K | |
| Investing Cash Flow | $120.0K | $780.0K | $-105.0K | $-661.0K | $-2M | $110.0K | · | · | · | · | · | · | |
| Stock Issued | $4M | $1M | · | · | · | · | · | · | · | · | $0 | $5.0K | |
| Stock Repurchased | · | · | · | · | · | · | · | $0 | $1M | $742.0K | $0 | · | |
| Net Stock Activity | · | $1M | · | · | · | · | · | $0 | $-1M | $-742.0K | $0 | $5.0K | |
| Dividends Paid | · | · | · | · | · | · | · | $0 | $2M | $3M | $3M | $2M | |
| Financing Cash Flow | $2M | $2M | $1M | · | $0 | $-384.0K | · | · | · | · | · | · | |
| Net Change in Cash | $1M | $2M | $-183.0K | $-1M | $-2M | $-540.0K | $-3M | $412.0K | $-25M | $4M | $3M | $5M | |
| Free Cash Flow | · | · | $-1M | · | · | $-280.0K | $-4M | $-7M | $-26M | $405.0K | $8M | $9M |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | · | -499.3% | 140.7% | -210.5% | · | -4.1% | -31.1% | -150.9% | -86.4% | 13.5% | 72.1% | 72.0% | |
| Pretax Margin | · | -297.6% | 133.0% | -205.4% | · | 7.2% | -15.3% | -203.4% | · | · | · | · | |
| ROA | · | -34.7% | -79.7% | -10.4% | · | -0.54% | -2.8% | -33.9% | -56.9% | 5.0% | 9.0% | 13.1% | |
| ROE | · | -70.5% | -149.3% | -12.2% | · | -0.63% | -3.8% | -69.2% | -148.0% | 6.7% | 12.5% | 11.1% |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.1 | -0.6 | 0.0 | · | 0.1 | 0.1 | 0.2 | 0.7 | 0.4 | 0.1 | 0.2 | |
| Receivables Turnover | · | · | -141.0 | · | · | · | · | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $0.62 | $0.91 | $2.60 | · | $1.40 | $1.40 | $1.45 | $2.43 | $6.28 | $6.11 | $6.12 | |
| Revenue / Share | · | $0.09 | $-1.20 | $0.15 | · | $0.21 | $0.17 | $0.66 | $4.10 | $3.16 | $1.05 | · | |
| Cash Flow / Share | · | $-0.20 | $-0.21 | $-0.14 | · | $-0.05 | $-0.76 | $-1.16 | $-4.53 | $0.07 | $1.34 | · | |
| Cash / Share | · | $0.33 | $0.08 | $0.21 | · | $0.97 | $1.04 | $1.41 | $1.35 | $2.07 | $1.42 | $0.89 | |
| Dividend Paid / Share | · | · | · | · | · | $0.00 | $0.00 | $0.00 | $0.36 | $0.48 | $0.48 | $0.48 | |
| EPS (TTM) | $-0.28 | $-0.45 | $-1.69 | $-0.31 | $1.49 | $-0.01 | $-0.05 | $-1.00 | $-3.55 | $0.43 | $0.76 | $0.82 |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 372.0% | · | · | -91.7% | 742.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 44.7% | -62.3% | · | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 16.2% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3M | $546.0K | $-7M | $850.0K | $10M | $1M | $981.0K | $4M | $24M | $19M | $6M | $6M | |
| Net Income TTM | $-2M | $-3M | $-10M | $-2M | $9M | $-50.0K | $-305.0K | $-6M | $-21M | $3M | $5M | $4M | |
| P/E | -0.9 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 0.3 | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -107.7% | · | · | · | · | · | · | · | · | · | · | · | |
| Payout Ratio | · | · | · | · | · | · | · | 0.00% | -10.2% | 111.8% | 63.2% | 42.7% | |
| Annual Payout | · | · | · | · | · | · | · | $0 | $2M | $3M | $3M | $2M |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $940.0K | $623.0K | $576.0K | $645.0K | $664.0K | $692.0K | $422.0K | $205.0K | $44.0K | $-125.0K | $-2M | $-6M | $691.0K | $546.0K | $1M | $-696.0K | |
| SG&A Expense | $603.0K | $522.0K | $530.0K | $754.0K | $1M | $505.0K | $431.0K | $432.0K | $566.0K | $488.0K | $474.0K | $628.0K | $677.0K | $404.0K | $363.0K | $323.0K | |
| Operating Expenses | $647.0K | $583.0K | $1M | $815.0K | $4M | $570.0K | $497.0K | $498.0K | $628.0K | · | · | $688.0K | $697.0K | $404.0K | · | $1M | |
| Pretax Income | $292.0K | $38.0K | $224.0K | $-172.0K | $-2M | $-125.0K | $-321.0K | $-540.0K | $-821.0K | $-905.0K | $-2M | $-7M | $-6.0K | $142.0K | $679.0K | $-2M | |
| Net Income | $176.0K | $22.0K | $120.0K | $-187.0K | $-2M | $-139.0K | $-460.0K | $-540.0K | $-821.0K | $-905.0K | $-3M | $-7M | $-85.0K | $142.0K | $678.0K | $-2M | |
| EPS (Basic) | $0.02 | · | $0.01 | $-0.02 | $-0.25 | $-0.02 | $-0.07 | $-0.09 | $-0.14 | $-0.15 | $-0.46 | $-1.24 | $-0.01 | $0.02 | $-0.62 | $0.37 | |
| EPS (Diluted) | $0.02 | · | $0.01 | $-0.02 | $-0.25 | $-0.02 | $-0.07 | $-0.09 | $-0.14 | $-0.15 | $-0.46 | $-1.24 | $-0.01 | $0.02 | $-0.62 | $0.37 | |
| Shares (Basic) | 8,101,374 | 7,799,832 | · | 7,664,122 | 7,442,922 | 6,899,062 | · | 6,121,020 | 6,010,561 | 6,005,162 | · | 5,870,234 | 5,870,234 | 5,857,643 | · | 5,781,587 | |
| Shares (Diluted) | 8,101,374 | 7,799,832 | · | 7,664,122 | 7,442,922 | 6,899,062 | · | 6,121,020 | 6,010,561 | 6,005,162 | · | 5,870,234 | 5,870,234 | 5,857,643 | · | 5,781,587 |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $885.0K | $268.0K | $726.0K | $4M | $5M | $2M | $1M | $4M | $532.0K | $495.0K | $2M | $3M | $729.0K | $1M | $2M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | $100.0K | · | · | · | · | · | |
| PP&E (Net) | $14.0K | $15.0K | $16.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $2.0K | $2.0K | $4.0K | $5.0K | $7.0K | $8.0K | $5.0K | $6.0K | |
| PP&E (Gross) | · | · | $146.0K | · | · | · | $135.0K | · | · | · | $135.0K | · | · | · | $130.0K | · | |
| Accum. Depreciation | · | · | $130.0K | · | · | · | $134.0K | · | · | · | $131.0K | · | · | · | $125.0K | · | |
| Total Assets | $20M | $9M | $8M | $9M | $9M | $10M | $7M | $7M | $8M | $7M | $8M | $11M | $19M | $17M | $17M | $16M | |
| Short-term Debt | $118.0K | $118.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $1M | $2M | $2M | $2M | $3M | $1M | $2M | $4M | $4M | $3M | $3M | $3M | $4M | $2M | $2M | $2M | |
| Total Debt | $118.0K | $118.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | |
| Paid-in Capital | $39M | $38M | $38M | $38M | $37M | · | $34M | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-32M | $-32M | $-32M | $-32M | $-32M | $-30M | $-30M | $-30M | $-29M | $-28M | $-27M | $-25M | $-17M | $-17M | $-17M | $-18M | |
| Stockholders' Equity | $7M | $6M | $6M | $6M | $5M | $7M | $4M | $4M | $4M | $4M | $5M | $8M | $15M | $15M | $15M | $14M | |
| Liabilities + Equity | $20M | $9M | $8M | $9M | $9M | $10M | $7M | $7M | $8M | $7M | $8M | $11M | $19M | $17M | $17M | $16M | |
| Shares Outstanding | 8,101,374 | 7,801,374 | 7,664,122 | 7,664,122 | 7,442,922 | 7,442,922 | 6,379,002 | 6,150,556 | 6,036,579 | 6,006,661 | 5,870,234 | 5,870,234 | 5,870,234 | 5,866,234 | 5,769,587 | 5,781,587 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.0K | $1.0K | · | · | · | · | $0 | $1.0K | $0 | $2.0K | $1.0K | $2.0K | $1.0K | $2.0K | $1.0K | $1.0K | |
| Stock-based Comp | $45.0K | $82.0K | $86.0K | $154.0K | $70.0K | $108.0K | $56.0K | $72.0K | $34.0K | $72.0K | $56.0K | $93.0K | $55.0K | $54.0K | $31.0K | $32.0K | |
| Operating Cash Flow | $-267.0K | $210.0K | $433.0K | $118.0K | $-2M | $272.0K | $-231.0K | $2M | $-430.0K | $-276.0K | $96.0K | $258.0K | $-1M | $-140.0K | $-147.0K | $-207.0K | |
| CapEx | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $5.0K | · | · | |
| Investing Cash Flow | · | · | $57.0K | $0 | $0 | $63.0K | $332.0K | $0 | $0 | $448.0K | $0 | $-100.0K | $0 | $-5.0K | $-285.0K | $0 | |
| Stock Issued | · | · | $0 | $403.0K | $0 | $3M | $724.0K | $332.0K | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $3M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $12M | $1M | $-690.0K | $405.0K | $-773.0K | $3M | $971.0K | $-863.0K | $-292.0K | $395.0K | $0 | $2.0K | $1M | $-163.0K | · | · | |
| Net Change in Cash | $12M | $1M | $-200.0K | $523.0K | $-3M | $4M | $1M | $836.0K | $-327.0K | $567.0K | $96.0K | $160.0K | $-131.0K | $-308.0K | $-432.0K | $-207.0K | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-145.0K | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 18.7% | 3.5% | · | -29.0% | -282.1% | -20.1% | · | -263.4% | -1865.9% | 724.0% | · | 114.4% | -12.3% | 26.0% | · | 309.9% | |
| Pretax Margin | 31.1% | 6.1% | · | -26.7% | -301.8% | -18.1% | · | -142.9% | -1327.3% | 538.4% | · | 110.8% | -0.87% | 26.0% | · | 309.9% | |
| ROA | 1.2% | 0.23% | · | -2.3% | -22.0% | -1.6% | · | -5.8% | -6.2% | -7.5% | · | -53.8% | -0.47% | 0.84% | · | -13.3% | |
| ROE | 2.9% | 0.34% | · | -4.0% | -41.0% | -2.4% | · | -9.3% | -8.7% | -9.2% | · | -65.7% | -0.54% | 0.90% | · | -14.7% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | 0.0 | -0.0 | · | -0.5 | 0.0 | 0.0 | · | -0.0 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.81 | $0.77 | · | $0.74 | $0.72 | $0.95 | · | $0.59 | $0.63 | $0.75 | · | $1.35 | $2.58 | $2.59 | · | $2.47 | |
| Revenue / Share | $0.12 | $0.08 | · | $0.08 | $0.09 | $0.10 | · | $0.03 | $0.01 | $-0.02 | · | $-1.09 | $0.00 | $0.09 | · | $-0.12 | |
| Cash Flow / Share | · | $0.03 | · | · | · | $0.04 | · | · | · | $0.02 | · | · | · | $-0.02 | · | · | |
| Cash / Share | $0.51 | $0.11 | · | $0.09 | $0.52 | $0.67 | · | $0.23 | $0.60 | $0.09 | · | $0.31 | $0.53 | $0.12 | · | $0.38 | |
| EPS (TTM) | · | $-0.28 | · | $-0.36 | $-0.43 | $-0.32 | · | $-0.84 | $-1.99 | $-1.86 | · | $-1.85 | $-0.24 | $-0.22 | · | $0.58 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3M | $3M | · | $2M | $2M | $1M | · | $-2M | $-8M | $-8M | · | $-4M | $2M | $1M | · | · | |
| Net Income TTM | $131.0K | $-2M | · | $-3M | $-3M | $-2M | · | $-5M | $-12M | $-11M | · | $-7M | $-1M | $-1M | · | $-904.0K | |
| Market Cap | $868.5K | $836.3K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Enterprise Value | $-3M | $69.3K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | · | -0.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/S | 0.3 | 0.3 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | 0.1 | 0.1 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 0.1 | 0.1 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | 4.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | -1.1 | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | · | -261.2% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $3M | $546.0K | $-7M | $850.0K | $10M |
| Net Gelir | $-2M | $-3M | $-10M | $-2M | $9M |
| Seyreltilmiş Hisse Başı Kâr | $-0.28 | $-0.45 | $-1.69 | $-0.31 | $1.49 |
Bu beyan için veri yok
Bu beyanı oluşturmak için henüz yeterli temel verisi yok.
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | · | · | $-1M | · | · |
Kurumsal Sahipler (13F) 5 dosya · $53K toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
5
Tutulan Değer
$53K
Yeni pozisyonlar
0
Çıkan pozisyonlar
1
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 0 (-1 önceki Ç'ye göre) | 1 (0 önceki Ç'ye göre) | 0 (-1 önceki Ç'ye göre) | 1 (+1 önceki Ç'ye göre) | -31K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| LPL Financial LLC | $47.257 | 713.852 | 88,82% | Hisse senetleri |
| MERCER GLOBAL ADVISORS INC /ADV | $3.145 | 47.500 | 5,91% | Hisse senetleri |
| HARBOR INVESTMENT ADVISORY, LLC | $1.589 | 24.000 | 2,99% | Hisse senetleri |
| UBS Group AG | $1.179 | 17.866 | 2,22% | Hisse senetleri |
| CLEAR STREET LLC | $33 | 100 | 0,06% | Hisse senetleri |
Aktivistler ve %5+ sahipler 4 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| MARTIN ALLAN S., Marie B. Martin, Fleur de Lis Partners, LLLP, Allan S Martin Childrens IRRV Trust ×3 başvurular | 17 Nisan 2026 | 9,30% | Değişiklik | Pasif yatırım | SEC |
| Allan S. Martin, Marie B. Martin, Fleur de Lis Partners, LLLP, Allan S Martin Children’s IRRV Trust, Benjamin A. Martin, Katherine M. Sogolow, Martin Family Foundation, Inc. | 31 Temmuz 2023 | · | İlk başvuru | Pasif yatırım | SEC |
| ACTIVIST INVESTING LLC, CUSTODIAN VENTURES LLC, DAVID ELLIOT LAZAR | 04 Nisan 2022 | · | İlk başvuru | · | SEC |
| Farnam Street Partners, L.P., FS Special Opportunities I Fund, L.P., Farnam Street Capital, Inc., Raymond E. Cabillot, Peter O. Haeg ×3 başvurular | 06 Ekim 2020 | · | İlk başvuru | Pasif yatırım | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 13, 2026